Review RAPIVAB information here.
RAPIVAB is the first full course of antiviral influenza therapy in a single intravenous dose. RAPIVAB is FDA approved for people aged 2 and older and helps to treat acute uncomplicated influenza with just one 15- to 30-minute IV infusion.1
RAPIVAB is an influenza virus neuraminidase inhibitor indicated for the treatment of acute uncomplicated influenza in patients 2 years and older who have been symptomatic for no more than two days.
- RAPIVAB injection is a clear, colorless, sterile, isotonic solution.
- Each single-use vial contains 200 mg per 20 mL (10 mg/mL) of peramivir in a clear glass vial. RAPIVAB injection is supplied in cartons containing 3 single-use vials.
Store vials of RAPIVAB injection in original cartons at 20°C to 25°C (68°F to 77°F). Excursions are permitted to 15°C to 30°C (59°F to 86°F). Do not use if seal over bottle opening is broken or missing.
Ask about RAPIVAB® today.
Please call customer service at (855) 358-8966 for more information.
Please call customer service at (855) 358-8966 to order RAPIVAB® today